0001213900-23-072561.txt : 20230830 0001213900-23-072561.hdr.sgml : 20230830 20230830215231 ACCESSION NUMBER: 0001213900-23-072561 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230817 FILED AS OF DATE: 20230830 DATE AS OF CHANGE: 20230830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hubbell Randolph W CENTRAL INDEX KEY: 0001984207 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40228 FILM NUMBER: 231226838 MAIL ADDRESS: STREET 1: C/O CARMELL THERAPEUTICS CORPORATION STREET 2: 2403 SIDNEY STREET, SUITE 300 CITY: PITTSBURGH STATE: PA ZIP: 15203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Carmell Corp CENTRAL INDEX KEY: 0001842939 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-494-3296 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Carmell Therapeutics Corp DATE OF NAME CHANGE: 20230727 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA HEALTHCARE ACQUISITION CORP III DATE OF NAME CHANGE: 20210127 4 1 ownership.xml X0508 4 2023-08-17 0 0001842939 Carmell Corp CTCX 0001984207 Hubbell Randolph W C/O CARMELL CORPORATION 2403 SIDNEY STREET, SUITE 300 PITTSBURGH PA 15203 1 1 0 0 President and CEO 0 Common Stock 2023-08-17 4 P 0 450 3.72 A 450 D Common Stock 2023-08-18 4 P 0 1200 3.735 A 1650 D Common Stock 2023-08-21 4 P 0 300 3.6667 A 1950 D Common Stock 2023-08-22 4 P 0 100 3.51 A 2050 D Common Stock 2023-08-23 4 P 0 200 3.605 A 2250 D Common Stock 2023-08-24 4 P 0 200 3.57 A 2450 D Common Stock 2023-08-25 4 P 0 200 3.50 A 2650 D Common Stock 2023-08-28 4 P 0 100 3.49 A 2750 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.54 to $3.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.65 to $3.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.63 to $3.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.58 to $3.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 4. /s/ Randolph W. Hubbell 2023-08-30